Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP versus hyaluronic acid for mild knee osteoarthritis
IRCT20250805066771N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Oct 2025
- Countries
- 1
01
Overview
Phase 3, single-blind trial of platelet-rich plasma and hyaluronic acid in knee osteoarthritis (OA) (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoints: Pain, Physical function and 1 more. Started Oct 2025; status: completed.
02
Drugs
platelet-rich plasmahyaluronic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20250805066771N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250805066771N1.